| # | Drug | Count |
|---|---|---|
| 0 | ETANERCEPT | 278 |
| 1 | INFLIXIMAB | 278 |
| 2 | METHOTREXATE SODIUM | 278 |
| 3 | TOCILIZUMAB | 278 |
| 4 | ABATACEPT | 277 |
| 5 | ADALIMUMAB | 276 |
| 6 | SULFASALAZINE | 276 |
| 7 | ANAKINRA | 274 |
| 8 | METHOTREXATE | 262 |
| 9 | PREDNISONE | 262 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIAMCINOLONE HEXACETONIDE | 124 | 0.5586 |
| 1 | VACCINIA IMMUNE GLOBULIN (HUMAN) | 1 | 0.0357 |
| 2 | ANAKINRA | 274 | 0.0221 |
| 3 | TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05% | 113 | 0.0099 |
| 4 | TRIAMCINOLONE ACETONIDE | 113 | 0.0050 |
| 5 | SULFASALAZINE | 276 | 0.0044 |
| 6 | HUMAN IMMUNOGLOBULIN G | 29 | 0.0039 |
| 7 | TOCILIZUMAB | 278 | 0.0033 |
| 8 | ABATACEPT | 277 | 0.0026 |
| 9 | HYDROXYCHLOROQUINE SULFATE | 156 | 0.0021 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 292 |
| 1 | Interleukin-6 Receptor Antagonist [EPC] | 278 |
| 2 | Aminosalicylate [EPC] | 277 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 277 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 274 |
| 5 | Corticosteroid [EPC] | 272 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 262 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 209 |
| 8 | Vitamin B12 [EPC] | 56 |
| 9 | Vitamin C [EPC] | 56 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-1 Receptor Antagonist [EPC] | 274 | 0.0221 |
| 1 | Human Immunoglobulin G [EPC] | 30 | 0.0038 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 278 | 0.0030 |
| 3 | Aminosalicylate [EPC] | 277 | 0.0027 |
| 4 | Selective T Cell Costimulation Modulator [EPC] | 277 | 0.0026 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 262 | 0.0008 |
| 6 | Tumor Necrosis Factor Blocker [EPC] | 292 | 0.0004 |
| 7 | Corticosteroid [EPC] | 272 | 0.0003 |
| 8 | Vitamin D [EPC] | 56 | 0.0002 |
| 9 | Nonsteroidal Anti-inflammatory Drug [EPC] | 209 | 0.0002 |